nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP19A1—Betamethasone—systemic lupus erythematosus	0.0992	0.167	CbGbCtD
Mefloquine—BCHE—Triamcinolone—systemic lupus erythematosus	0.0964	0.163	CbGbCtD
Mefloquine—CYP19A1—Dexamethasone—systemic lupus erythematosus	0.0577	0.0974	CbGbCtD
Mefloquine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0323	0.0544	CbGbCtD
Mefloquine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0245	0.0413	CbGbCtD
Mefloquine—ABCB1—Betamethasone—systemic lupus erythematosus	0.021	0.0354	CbGbCtD
Mefloquine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0207	0.0349	CbGbCtD
Mefloquine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0196	0.0331	CbGbCtD
Mefloquine—ABCB1—Prednisone—systemic lupus erythematosus	0.0196	0.033	CbGbCtD
Mefloquine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0193	0.0326	CbGbCtD
Mefloquine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0185	0.0313	CbGbCtD
Mefloquine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0175	0.0295	CbGbCtD
Mefloquine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0169	0.0285	CbGbCtD
Mefloquine—HBA1—urine—systemic lupus erythematosus	0.0156	0.121	CbGeAlD
Mefloquine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0147	0.0247	CbGbCtD
Mefloquine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0147	0.0247	CbGbCtD
Mefloquine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0126	0.0212	CbGbCtD
Mefloquine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0124	0.0209	CbGbCtD
Mefloquine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0122	0.0206	CbGbCtD
Mefloquine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0118	0.0198	CbGbCtD
Mefloquine—CYP3A4—Prednisone—systemic lupus erythematosus	0.0117	0.0198	CbGbCtD
Mefloquine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0115	0.0194	CbGbCtD
Mefloquine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0111	0.0187	CbGbCtD
Mefloquine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00981	0.0165	CbGbCtD
Mefloquine—BCHE—diaphragm—systemic lupus erythematosus	0.00868	0.0674	CbGeAlD
Mefloquine—HBA2—endothelium—systemic lupus erythematosus	0.0084	0.0653	CbGeAlD
Mefloquine—HBA1—blood plasma—systemic lupus erythematosus	0.00813	0.0631	CbGeAlD
Mefloquine—HBA2—blood plasma—systemic lupus erythematosus	0.00746	0.058	CbGeAlD
Mefloquine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00731	0.0123	CbGbCtD
Mefloquine—HBA1—connective tissue—systemic lupus erythematosus	0.00433	0.0336	CbGeAlD
Mefloquine—HBA2—connective tissue—systemic lupus erythematosus	0.00397	0.0309	CbGeAlD
Mefloquine—HBA1—skin of body—systemic lupus erythematosus	0.00391	0.0303	CbGeAlD
Mefloquine—HBA1—kidney—systemic lupus erythematosus	0.00368	0.0286	CbGeAlD
Mefloquine—HBA2—skin of body—systemic lupus erythematosus	0.00359	0.0279	CbGeAlD
Mefloquine—HBA2—kidney—systemic lupus erythematosus	0.00338	0.0263	CbGeAlD
Mefloquine—HBA1—lymphoid tissue—systemic lupus erythematosus	0.00316	0.0246	CbGeAlD
Mefloquine—HBA2—lymphoid tissue—systemic lupus erythematosus	0.0029	0.0226	CbGeAlD
Mefloquine—HBA1—bone marrow—systemic lupus erythematosus	0.00288	0.0224	CbGeAlD
Mefloquine—HBA2—bone marrow—systemic lupus erythematosus	0.00264	0.0205	CbGeAlD
Mefloquine—HBA1—lung—systemic lupus erythematosus	0.00261	0.0203	CbGeAlD
Mefloquine—HBA1—nervous system—systemic lupus erythematosus	0.00242	0.0188	CbGeAlD
Mefloquine—HBA2—lung—systemic lupus erythematosus	0.0024	0.0186	CbGeAlD
Mefloquine—HBA1—central nervous system—systemic lupus erythematosus	0.00233	0.0181	CbGeAlD
Mefloquine—HBA2—nervous system—systemic lupus erythematosus	0.00222	0.0172	CbGeAlD
Mefloquine—HBA2—central nervous system—systemic lupus erythematosus	0.00214	0.0166	CbGeAlD
Mefloquine—CYP3A4—urine—systemic lupus erythematosus	0.00211	0.0164	CbGeAlD
Mefloquine—CYP2D6—urine—systemic lupus erythematosus	0.00208	0.0162	CbGeAlD
Mefloquine—BCHE—blood plasma—systemic lupus erythematosus	0.00164	0.0127	CbGeAlD
Mefloquine—ADORA1—kidney—systemic lupus erythematosus	0.00152	0.0118	CbGeAlD
Mefloquine—ADORA2A—lymphoid tissue—systemic lupus erythematosus	0.00151	0.0117	CbGeAlD
Mefloquine—ADORA1—cortex of kidney—systemic lupus erythematosus	0.00148	0.0115	CbGeAlD
Mefloquine—ADORA1—tendon—systemic lupus erythematosus	0.00123	0.00953	CbGeAlD
Mefloquine—ACHE—tendon—systemic lupus erythematosus	0.00122	0.00947	CbGeAlD
Mefloquine—CYP19A1—connective tissue—systemic lupus erythematosus	0.00121	0.0094	CbGeAlD
Mefloquine—ADORA2A—nervous system—systemic lupus erythematosus	0.00115	0.00897	CbGeAlD
Mefloquine—ADORA2A—central nervous system—systemic lupus erythematosus	0.00111	0.00864	CbGeAlD
Mefloquine—CYP3A4—blood plasma—systemic lupus erythematosus	0.0011	0.00857	CbGeAlD
Mefloquine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00109	0.00843	CbGeAlD
Mefloquine—ADORA1—lung—systemic lupus erythematosus	0.00108	0.00837	CbGeAlD
Mefloquine—ADORA1—nervous system—systemic lupus erythematosus	0.000997	0.00775	CbGeAlD
Mefloquine—ADORA1—central nervous system—systemic lupus erythematosus	0.00096	0.00746	CbGeAlD
Mefloquine—BCHE—nephron tubule—systemic lupus erythematosus	0.000845	0.00656	CbGeAlD
Mefloquine—BCHE—skin of body—systemic lupus erythematosus	0.000787	0.00612	CbGeAlD
Mefloquine—ABCB1—blood plasma—systemic lupus erythematosus	0.000781	0.00606	CbGeAlD
Mefloquine—CYP19A1—nervous system—systemic lupus erythematosus	0.000676	0.00525	CbGeAlD
Mefloquine—CYP19A1—central nervous system—systemic lupus erythematosus	0.000651	0.00506	CbGeAlD
Mefloquine—BCHE—bone marrow—systemic lupus erythematosus	0.000581	0.00451	CbGeAlD
Mefloquine—BCHE—lung—systemic lupus erythematosus	0.000526	0.00409	CbGeAlD
Mefloquine—CYP3A4—kidney—systemic lupus erythematosus	0.0005	0.00388	CbGeAlD
Mefloquine—CYP2D6—kidney—systemic lupus erythematosus	0.000492	0.00382	CbGeAlD
Mefloquine—BCHE—nervous system—systemic lupus erythematosus	0.000487	0.00378	CbGeAlD
Mefloquine—BCHE—central nervous system—systemic lupus erythematosus	0.000469	0.00364	CbGeAlD
Mefloquine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000403	0.00313	CbGeAlD
Mefloquine—ABCB1—kidney—systemic lupus erythematosus	0.000354	0.00275	CbGeAlD
Mefloquine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000345	0.00268	CbGeAlD
Mefloquine—CYP3A4—nervous system—systemic lupus erythematosus	0.000328	0.00255	CbGeAlD
Mefloquine—CYP2D6—nervous system—systemic lupus erythematosus	0.000323	0.00251	CbGeAlD
Mefloquine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000316	0.00245	CbGeAlD
Mefloquine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000311	0.00241	CbGeAlD
Mefloquine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000304	0.00236	CbGeAlD
Mefloquine—ABCB1—bone marrow—systemic lupus erythematosus	0.000277	0.00215	CbGeAlD
Mefloquine—ABCB1—lung—systemic lupus erythematosus	0.000251	0.00195	CbGeAlD
Mefloquine—ABCB1—nervous system—systemic lupus erythematosus	0.000232	0.0018	CbGeAlD
Mefloquine—ABCB1—central nervous system—systemic lupus erythematosus	0.000223	0.00174	CbGeAlD
Mefloquine—Myalgia—Betamethasone—systemic lupus erythematosus	0.000161	0.000745	CcSEcCtD
Mefloquine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000161	0.000744	CcSEcCtD
Mefloquine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000161	0.000744	CcSEcCtD
Mefloquine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000161	0.000743	CcSEcCtD
Mefloquine—Anxiety—Betamethasone—systemic lupus erythematosus	0.000161	0.000743	CcSEcCtD
Mefloquine—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000159	0.000737	CcSEcCtD
Mefloquine—Discomfort—Betamethasone—systemic lupus erythematosus	0.000159	0.000737	CcSEcCtD
Mefloquine—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000159	0.000736	CcSEcCtD
Mefloquine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000159	0.000734	CcSEcCtD
Mefloquine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000158	0.000729	CcSEcCtD
Mefloquine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000157	0.000727	CcSEcCtD
Mefloquine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.000726	CcSEcCtD
Mefloquine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.000726	CcSEcCtD
Mefloquine—Nausea—Leflunomide—systemic lupus erythematosus	0.000157	0.000724	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000156	0.000722	CcSEcCtD
Mefloquine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000156	0.000721	CcSEcCtD
Mefloquine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000155	0.000719	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000155	0.000718	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000155	0.000716	CcSEcCtD
Mefloquine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000154	0.000715	CcSEcCtD
Mefloquine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000154	0.000715	CcSEcCtD
Mefloquine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000154	0.000715	CcSEcCtD
Mefloquine—Oedema—Betamethasone—systemic lupus erythematosus	0.000154	0.000715	CcSEcCtD
Mefloquine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000154	0.000712	CcSEcCtD
Mefloquine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000154	0.000711	CcSEcCtD
Mefloquine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000153	0.000708	CcSEcCtD
Mefloquine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000153	0.000707	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000153	0.000706	CcSEcCtD
Mefloquine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000153	0.000706	CcSEcCtD
Mefloquine—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000152	0.000706	CcSEcCtD
Mefloquine—Shock—Dexamethasone—systemic lupus erythematosus	0.000152	0.000703	CcSEcCtD
Mefloquine—Shock—Betamethasone—systemic lupus erythematosus	0.000152	0.000703	CcSEcCtD
Mefloquine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000152	0.000702	CcSEcCtD
Mefloquine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000151	0.000701	CcSEcCtD
Mefloquine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000151	0.000701	CcSEcCtD
Mefloquine—Agitation—Prednisone—systemic lupus erythematosus	0.000151	0.000701	CcSEcCtD
Mefloquine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000151	0.0007	CcSEcCtD
Mefloquine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000151	0.0007	CcSEcCtD
Mefloquine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000151	0.000697	CcSEcCtD
Mefloquine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000151	0.000697	CcSEcCtD
Mefloquine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00015	0.000693	CcSEcCtD
Mefloquine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.00015	0.000693	CcSEcCtD
Mefloquine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.00015	0.000692	CcSEcCtD
Mefloquine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.00015	0.000692	CcSEcCtD
Mefloquine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000149	0.000691	CcSEcCtD
Mefloquine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000149	0.000691	CcSEcCtD
Mefloquine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000149	0.000689	CcSEcCtD
Mefloquine—Malaise—Prednisone—systemic lupus erythematosus	0.000149	0.000688	CcSEcCtD
Mefloquine—Vertigo—Prednisone—systemic lupus erythematosus	0.000148	0.000685	CcSEcCtD
Mefloquine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000148	0.000684	CcSEcCtD
Mefloquine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000684	CcSEcCtD
Mefloquine—Syncope—Prednisone—systemic lupus erythematosus	0.000148	0.000684	CcSEcCtD
Mefloquine—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000148	0.000683	CcSEcCtD
Mefloquine—Urticaria—Prednisolone—systemic lupus erythematosus	0.000147	0.00068	CcSEcCtD
Mefloquine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000147	0.000679	CcSEcCtD
Mefloquine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000147	0.000679	CcSEcCtD
Mefloquine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000146	0.000678	CcSEcCtD
Mefloquine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000146	0.000676	CcSEcCtD
Mefloquine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000146	0.000675	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000145	0.00067	CcSEcCtD
Mefloquine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000144	0.000668	CcSEcCtD
Mefloquine—Hypotension—Betamethasone—systemic lupus erythematosus	0.000144	0.000668	CcSEcCtD
Mefloquine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000144	0.000666	CcSEcCtD
Mefloquine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000144	0.000664	CcSEcCtD
Mefloquine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000144	0.000664	CcSEcCtD
Mefloquine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000661	CcSEcCtD
Mefloquine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000661	CcSEcCtD
Mefloquine—Convulsion—Prednisone—systemic lupus erythematosus	0.000143	0.000661	CcSEcCtD
Mefloquine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000143	0.00066	CcSEcCtD
Mefloquine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.000659	CcSEcCtD
Mefloquine—Hypertension—Prednisone—systemic lupus erythematosus	0.000142	0.000658	CcSEcCtD
Mefloquine—Chills—Methotrexate—systemic lupus erythematosus	0.000142	0.000657	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000141	0.000651	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000141	0.000651	CcSEcCtD
Mefloquine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00065	CcSEcCtD
Mefloquine—Myalgia—Prednisone—systemic lupus erythematosus	0.00014	0.000649	CcSEcCtD
Mefloquine—Arthralgia—Prednisone—systemic lupus erythematosus	0.00014	0.000649	CcSEcCtD
Mefloquine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00014	0.000649	CcSEcCtD
Mefloquine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00014	0.000648	CcSEcCtD
Mefloquine—Anxiety—Prednisone—systemic lupus erythematosus	0.00014	0.000647	CcSEcCtD
Mefloquine—Alopecia—Methotrexate—systemic lupus erythematosus	0.00014	0.000647	CcSEcCtD
Mefloquine—Insomnia—Betamethasone—systemic lupus erythematosus	0.00014	0.000646	CcSEcCtD
Mefloquine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00014	0.000646	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000139	0.000645	CcSEcCtD
Mefloquine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000139	0.000644	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000139	0.000643	CcSEcCtD
Mefloquine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000139	0.000642	CcSEcCtD
Mefloquine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000139	0.000642	CcSEcCtD
Mefloquine—Discomfort—Prednisone—systemic lupus erythematosus	0.000139	0.000641	CcSEcCtD
Mefloquine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000139	0.000641	CcSEcCtD
Mefloquine—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000138	0.000637	CcSEcCtD
Mefloquine—Erythema—Methotrexate—systemic lupus erythematosus	0.000138	0.000637	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000136	0.000631	CcSEcCtD
Mefloquine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000136	0.000629	CcSEcCtD
Mefloquine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000136	0.000629	CcSEcCtD
Mefloquine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000136	0.000628	CcSEcCtD
Mefloquine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000135	0.000626	CcSEcCtD
Mefloquine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000135	0.000624	CcSEcCtD
Mefloquine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000135	0.000623	CcSEcCtD
Mefloquine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000135	0.000622	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000135	0.000622	CcSEcCtD
Mefloquine—Oedema—Prednisone—systemic lupus erythematosus	0.000135	0.000622	CcSEcCtD
Mefloquine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000134	0.000621	CcSEcCtD
Mefloquine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000134	0.000621	CcSEcCtD
Mefloquine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000134	0.000621	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000133	0.000617	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000133	0.000617	CcSEcCtD
Mefloquine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000133	0.000616	CcSEcCtD
Mefloquine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000133	0.000616	CcSEcCtD
Mefloquine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000133	0.000616	CcSEcCtD
Mefloquine—Shock—Prednisone—systemic lupus erythematosus	0.000132	0.000612	CcSEcCtD
Mefloquine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000132	0.00061	CcSEcCtD
Mefloquine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000131	0.000607	CcSEcCtD
Mefloquine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.000607	CcSEcCtD
Mefloquine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000131	0.000605	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.00013	0.000602	CcSEcCtD
Mefloquine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.00013	0.000601	CcSEcCtD
Mefloquine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.00013	0.0006	CcSEcCtD
Mefloquine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000129	0.000598	CcSEcCtD
Mefloquine—Rash—Cyclosporine—systemic lupus erythematosus	0.000128	0.000593	CcSEcCtD
Mefloquine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000128	0.000593	CcSEcCtD
Mefloquine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000128	0.000592	CcSEcCtD
Mefloquine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000128	0.000591	CcSEcCtD
Mefloquine—Headache—Cyclosporine—systemic lupus erythematosus	0.000127	0.00059	CcSEcCtD
Mefloquine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000127	0.000589	CcSEcCtD
Mefloquine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000127	0.000589	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000126	0.000584	CcSEcCtD
Mefloquine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000126	0.000584	CcSEcCtD
Mefloquine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000126	0.000584	CcSEcCtD
Mefloquine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000125	0.00058	CcSEcCtD
Mefloquine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000579	CcSEcCtD
Mefloquine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.000579	CcSEcCtD
Mefloquine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.000578	CcSEcCtD
Mefloquine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.000575	CcSEcCtD
Mefloquine—Malaise—Methotrexate—systemic lupus erythematosus	0.000124	0.000575	CcSEcCtD
Mefloquine—Vertigo—Methotrexate—systemic lupus erythematosus	0.000124	0.000573	CcSEcCtD
Mefloquine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000124	0.000572	CcSEcCtD
Mefloquine—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000123	0.00057	CcSEcCtD
Mefloquine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000123	0.000568	CcSEcCtD
Mefloquine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000123	0.000568	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000123	0.000567	CcSEcCtD
Mefloquine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000122	0.000566	CcSEcCtD
Mefloquine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000122	0.000565	CcSEcCtD
Mefloquine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000122	0.000565	CcSEcCtD
Mefloquine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000122	0.000565	CcSEcCtD
Mefloquine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000122	0.000565	CcSEcCtD
Mefloquine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000122	0.000565	CcSEcCtD
Mefloquine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000122	0.000564	CcSEcCtD
Mefloquine—Insomnia—Prednisone—systemic lupus erythematosus	0.000122	0.000563	CcSEcCtD
Mefloquine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000121	0.000559	CcSEcCtD
Mefloquine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000121	0.000559	CcSEcCtD
Mefloquine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00012	0.000557	CcSEcCtD
Mefloquine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000556	CcSEcCtD
Mefloquine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000553	CcSEcCtD
Mefloquine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000119	0.000552	CcSEcCtD
Mefloquine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000118	0.000548	CcSEcCtD
Mefloquine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000545	CcSEcCtD
Mefloquine—Chest pain—Methotrexate—systemic lupus erythematosus	0.000117	0.000543	CcSEcCtD
Mefloquine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000117	0.000543	CcSEcCtD
Mefloquine—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000117	0.000543	CcSEcCtD
Mefloquine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000117	0.000541	CcSEcCtD
Mefloquine—Rash—Prednisolone—systemic lupus erythematosus	0.000117	0.00054	CcSEcCtD
Mefloquine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000117	0.00054	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000116	0.000539	CcSEcCtD
Mefloquine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000116	0.000538	CcSEcCtD
Mefloquine—Fatigue—Prednisone—systemic lupus erythematosus	0.000116	0.000537	CcSEcCtD
Mefloquine—Headache—Prednisolone—systemic lupus erythematosus	0.000116	0.000537	CcSEcCtD
Mefloquine—Discomfort—Methotrexate—systemic lupus erythematosus	0.000116	0.000536	CcSEcCtD
Mefloquine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000532	CcSEcCtD
Mefloquine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000527	CcSEcCtD
Mefloquine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000527	CcSEcCtD
Mefloquine—Confusional state—Methotrexate—systemic lupus erythematosus	0.000113	0.000524	CcSEcCtD
Mefloquine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000524	CcSEcCtD
Mefloquine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000113	0.000521	CcSEcCtD
Mefloquine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000112	0.00052	CcSEcCtD
Mefloquine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000112	0.00052	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000111	0.000513	CcSEcCtD
Mefloquine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000111	0.000513	CcSEcCtD
Mefloquine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000111	0.000513	CcSEcCtD
Mefloquine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.00011	0.00051	CcSEcCtD
Mefloquine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.00011	0.000509	CcSEcCtD
Mefloquine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.00011	0.000509	CcSEcCtD
Mefloquine—Nausea—Prednisolone—systemic lupus erythematosus	0.00011	0.000509	CcSEcCtD
Mefloquine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000109	0.000506	CcSEcCtD
Mefloquine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000109	0.000506	CcSEcCtD
Mefloquine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000109	0.000505	CcSEcCtD
Mefloquine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000109	0.000503	CcSEcCtD
Mefloquine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000108	0.000501	CcSEcCtD
Mefloquine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000108	0.0005	CcSEcCtD
Mefloquine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000497	CcSEcCtD
Mefloquine—Rash—Triamcinolone—systemic lupus erythematosus	0.000107	0.000497	CcSEcCtD
Mefloquine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000107	0.000496	CcSEcCtD
Mefloquine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000495	CcSEcCtD
Mefloquine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000495	CcSEcCtD
Mefloquine—Urticaria—Prednisone—systemic lupus erythematosus	0.000107	0.000494	CcSEcCtD
Mefloquine—Headache—Triamcinolone—systemic lupus erythematosus	0.000107	0.000493	CcSEcCtD
Mefloquine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000106	0.000492	CcSEcCtD
Mefloquine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000106	0.000492	CcSEcCtD
Mefloquine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000106	0.000492	CcSEcCtD
Mefloquine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000106	0.000489	CcSEcCtD
Mefloquine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000106	0.000489	CcSEcCtD
Mefloquine—Hypotension—Methotrexate—systemic lupus erythematosus	0.000105	0.000486	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000102	0.000474	CcSEcCtD
Mefloquine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000102	0.000473	CcSEcCtD
Mefloquine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000102	0.000473	CcSEcCtD
Mefloquine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000102	0.00047	CcSEcCtD
Mefloquine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000101	0.000468	CcSEcCtD
Mefloquine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000101	0.000467	CcSEcCtD
Mefloquine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000467	CcSEcCtD
Mefloquine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.0001	0.000464	CcSEcCtD
Mefloquine—Somnolence—Methotrexate—systemic lupus erythematosus	9.99e-05	0.000462	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.91e-05	0.000459	CcSEcCtD
Mefloquine—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.9e-05	0.000458	CcSEcCtD
Mefloquine—Vomiting—Betamethasone—systemic lupus erythematosus	9.82e-05	0.000454	CcSEcCtD
Mefloquine—Vomiting—Dexamethasone—systemic lupus erythematosus	9.82e-05	0.000454	CcSEcCtD
Mefloquine—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.77e-05	0.000452	CcSEcCtD
Mefloquine—Rash—Betamethasone—systemic lupus erythematosus	9.74e-05	0.000451	CcSEcCtD
Mefloquine—Rash—Dexamethasone—systemic lupus erythematosus	9.74e-05	0.000451	CcSEcCtD
Mefloquine—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.73e-05	0.00045	CcSEcCtD
Mefloquine—Dermatitis—Betamethasone—systemic lupus erythematosus	9.73e-05	0.00045	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.71e-05	0.000449	CcSEcCtD
Mefloquine—Fatigue—Methotrexate—systemic lupus erythematosus	9.69e-05	0.000448	CcSEcCtD
Mefloquine—Headache—Betamethasone—systemic lupus erythematosus	9.68e-05	0.000448	CcSEcCtD
Mefloquine—Headache—Dexamethasone—systemic lupus erythematosus	9.68e-05	0.000448	CcSEcCtD
Mefloquine—Asthenia—Prednisone—systemic lupus erythematosus	9.65e-05	0.000447	CcSEcCtD
Mefloquine—Pruritus—Prednisone—systemic lupus erythematosus	9.52e-05	0.00044	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	9.31e-05	0.0015	CbGpPWpGaD
Mefloquine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	9.26e-05	0.000429	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD80—systemic lupus erythematosus	9.25e-05	0.00149	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PPARG—systemic lupus erythematosus	9.24e-05	0.00148	CbGpPWpGaD
Mefloquine—Diarrhoea—Prednisone—systemic lupus erythematosus	9.2e-05	0.000426	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	9.19e-05	0.000425	CcSEcCtD
Mefloquine—Nausea—Dexamethasone—systemic lupus erythematosus	9.17e-05	0.000424	CcSEcCtD
Mefloquine—Nausea—Betamethasone—systemic lupus erythematosus	9.17e-05	0.000424	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—JAK1—systemic lupus erythematosus	9.13e-05	0.00147	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—PPARG—systemic lupus erythematosus	9.09e-05	0.00146	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	9.08e-05	0.00146	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	9.05e-05	0.00145	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	8.94e-05	0.00144	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.94e-05	0.00144	CbGpPWpGaD
Mefloquine—Urticaria—Methotrexate—systemic lupus erythematosus	8.93e-05	0.000413	CcSEcCtD
Mefloquine—Dizziness—Prednisone—systemic lupus erythematosus	8.9e-05	0.000412	CcSEcCtD
Mefloquine—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.89e-05	0.000411	CcSEcCtD
Mefloquine—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.89e-05	0.000411	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	8.83e-05	0.00142	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	8.65e-05	0.00139	CbGpPWpGaD
Mefloquine—Vomiting—Prednisone—systemic lupus erythematosus	8.55e-05	0.000396	CcSEcCtD
Mefloquine—Rash—Prednisone—systemic lupus erythematosus	8.48e-05	0.000392	CcSEcCtD
Mefloquine—Dermatitis—Prednisone—systemic lupus erythematosus	8.47e-05	0.000392	CcSEcCtD
Mefloquine—Headache—Prednisone—systemic lupus erythematosus	8.43e-05	0.00039	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	8.34e-05	0.00134	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ALB—systemic lupus erythematosus	8.3e-05	0.00133	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	8.3e-05	0.00133	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	8.3e-05	0.00133	CbGpPWpGaD
Mefloquine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.28e-05	0.000383	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	8.23e-05	0.00132	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	8.13e-05	0.00131	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.11e-05	0.0013	CbGpPWpGaD
Mefloquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.07e-05	0.0013	CbGpPWpGaD
Mefloquine—Asthenia—Methotrexate—systemic lupus erythematosus	8.07e-05	0.000373	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	8.05e-05	0.00129	CbGpPWpGaD
Mefloquine—Nausea—Prednisone—systemic lupus erythematosus	7.99e-05	0.00037	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	7.97e-05	0.00128	CbGpPWpGaD
Mefloquine—Pruritus—Methotrexate—systemic lupus erythematosus	7.95e-05	0.000368	CcSEcCtD
Mefloquine—HBA2—Metabolism—NOS3—systemic lupus erythematosus	7.94e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCR5—systemic lupus erythematosus	7.94e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.87e-05	0.00126	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—systemic lupus erythematosus	7.81e-05	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—C3—systemic lupus erythematosus	7.76e-05	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—EP300—systemic lupus erythematosus	7.7e-05	0.00124	CbGpPWpGaD
Mefloquine—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.69e-05	0.000356	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.51e-05	0.00121	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	7.49e-05	0.0012	CbGpPWpGaD
Mefloquine—Dizziness—Methotrexate—systemic lupus erythematosus	7.43e-05	0.000344	CcSEcCtD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	7.28e-05	0.00117	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PTGS2—systemic lupus erythematosus	7.27e-05	0.00117	CbGpPWpGaD
Mefloquine—Vomiting—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000331	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—CD80—systemic lupus erythematosus	7.12e-05	0.00114	CbGpPWpGaD
Mefloquine—Rash—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000328	CcSEcCtD
Mefloquine—Dermatitis—Methotrexate—systemic lupus erythematosus	7.08e-05	0.000328	CcSEcCtD
Mefloquine—Headache—Methotrexate—systemic lupus erythematosus	7.04e-05	0.000326	CcSEcCtD
Mefloquine—HBA1—Metabolism—PPARG—systemic lupus erythematosus	7e-05	0.00112	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	6.92e-05	0.00111	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.91e-05	0.00111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.82e-05	0.0011	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—F2—systemic lupus erythematosus	6.81e-05	0.00109	CbGpPWpGaD
Mefloquine—Nausea—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000309	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—systemic lupus erythematosus	6.64e-05	0.00107	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.58e-05	0.00106	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.55e-05	0.00105	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.31e-05	0.00101	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—systemic lupus erythematosus	6.29e-05	0.00101	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.23e-05	0.001	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	6.15e-05	0.000989	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.15e-05	0.000987	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.13e-05	0.000985	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—systemic lupus erythematosus	6.13e-05	0.000984	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.1e-05	0.000981	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.07e-05	0.000975	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—EP300—systemic lupus erythematosus	6.04e-05	0.000971	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—NOS3—systemic lupus erythematosus	6.02e-05	0.000967	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—TYK2—systemic lupus erythematosus	6.01e-05	0.000965	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—C3—systemic lupus erythematosus	5.99e-05	0.000962	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	5.95e-05	0.000956	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.95e-05	0.000956	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—EP300—systemic lupus erythematosus	5.95e-05	0.000955	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.94e-05	0.000955	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	5.63e-05	0.000905	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.54e-05	0.00089	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PTGS2—systemic lupus erythematosus	5.51e-05	0.000884	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	5.49e-05	0.000881	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	5.47e-05	0.000879	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TLR9—systemic lupus erythematosus	5.39e-05	0.000865	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	5.34e-05	0.000858	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—F2—systemic lupus erythematosus	5.26e-05	0.000845	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.22e-05	0.000838	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.21e-05	0.000837	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	5.2e-05	0.000835	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	5.2e-05	0.000835	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CDKN1B—systemic lupus erythematosus	5.11e-05	0.00082	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.05e-05	0.000812	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—systemic lupus erythematosus	5.05e-05	0.00081	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ACE—systemic lupus erythematosus	5.04e-05	0.00081	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	5.04e-05	0.00081	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5e-05	0.000803	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	4.95e-05	0.000795	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.93e-05	0.000792	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.86e-05	0.000781	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CSK—systemic lupus erythematosus	4.8e-05	0.000771	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.77e-05	0.000767	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.73e-05	0.00076	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CDKN1A—systemic lupus erythematosus	4.71e-05	0.000757	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.71e-05	0.000757	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.69e-05	0.000753	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	4.69e-05	0.000753	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.6e-05	0.000738	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.59e-05	0.000737	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—EP300—systemic lupus erythematosus	4.58e-05	0.000736	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ACE—systemic lupus erythematosus	4.5e-05	0.000723	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.49e-05	0.000721	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.46e-05	0.000717	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.42e-05	0.00071	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NCF2—systemic lupus erythematosus	4.39e-05	0.000706	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—C3—systemic lupus erythematosus	4.38e-05	0.000704	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LYN—systemic lupus erythematosus	4.36e-05	0.000701	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.3e-05	0.000691	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.3e-05	0.000691	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.28e-05	0.000688	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.28e-05	0.000688	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.27e-05	0.000686	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TLR9—systemic lupus erythematosus	4.16e-05	0.000668	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	4.13e-05	0.000664	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.12e-05	0.000661	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.07e-05	0.000654	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.03e-05	0.000647	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.02e-05	0.000645	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.01e-05	0.000645	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—C3—systemic lupus erythematosus	3.98e-05	0.000639	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NAT2—systemic lupus erythematosus	3.97e-05	0.000638	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—systemic lupus erythematosus	3.9e-05	0.000626	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.85e-05	0.000618	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	3.82e-05	0.000614	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.8e-05	0.000611	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.79e-05	0.000609	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CSK—systemic lupus erythematosus	3.71e-05	0.000596	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.66e-05	0.000587	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NAT2—systemic lupus erythematosus	3.65e-05	0.000587	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NAT2—systemic lupus erythematosus	3.54e-05	0.000569	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.54e-05	0.000569	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.51e-05	0.000564	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—F2—systemic lupus erythematosus	3.5e-05	0.000561	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.49e-05	0.000561	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.46e-05	0.000556	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.45e-05	0.000554	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.41e-05	0.000548	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	3.39e-05	0.000545	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	3.38e-05	0.000544	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LYN—systemic lupus erythematosus	3.37e-05	0.000541	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.32e-05	0.000533	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.3e-05	0.000531	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.27e-05	0.000526	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PRL—systemic lupus erythematosus	3.18e-05	0.00051	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.16e-05	0.000507	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.15e-05	0.000505	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.12e-05	0.0005	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.1e-05	0.000498	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—C3—systemic lupus erythematosus	3.07e-05	0.000494	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	2.97e-05	0.000477	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—F2—systemic lupus erythematosus	2.95e-05	0.000475	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—systemic lupus erythematosus	2.94e-05	0.000472	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.9e-05	0.000466	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.84e-05	0.000456	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.83e-05	0.000454	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.82e-05	0.000453	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.71e-05	0.000435	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—F2—systemic lupus erythematosus	2.7e-05	0.000433	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	2.66e-05	0.000427	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—F2—systemic lupus erythematosus	2.64e-05	0.000423	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CCL2—systemic lupus erythematosus	2.63e-05	0.000423	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.61e-05	0.000419	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.59e-05	0.000416	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.59e-05	0.000416	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.54e-05	0.000408	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.53e-05	0.000407	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.53e-05	0.000406	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.48e-05	0.000399	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.45e-05	0.000394	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRL—systemic lupus erythematosus	2.45e-05	0.000394	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.41e-05	0.000387	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.41e-05	0.000386	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.37e-05	0.000381	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.35e-05	0.000378	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—C3—systemic lupus erythematosus	2.35e-05	0.000378	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CCL2—systemic lupus erythematosus	2.35e-05	0.000377	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.28e-05	0.000367	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.26e-05	0.000364	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—RXRA—systemic lupus erythematosus	2.23e-05	0.000358	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.22e-05	0.000356	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.18e-05	0.000351	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.15e-05	0.000346	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.07e-05	0.000333	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.07e-05	0.000332	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—F2—systemic lupus erythematosus	2.06e-05	0.000332	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—RXRA—systemic lupus erythematosus	2.05e-05	0.000329	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.04e-05	0.000328	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2e-05	0.000321	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—RXRA—systemic lupus erythematosus	1.99e-05	0.000319	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD80—systemic lupus erythematosus	1.98e-05	0.000318	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	1.96e-05	0.000315	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.9e-05	0.000305	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.87e-05	0.000301	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.86e-05	0.000298	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.84e-05	0.000296	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.84e-05	0.000296	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.83e-05	0.000294	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	1.82e-05	0.000292	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—C3—systemic lupus erythematosus	1.82e-05	0.000292	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.75e-05	0.000281	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.73e-05	0.000278	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.67e-05	0.000268	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.64e-05	0.000263	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.63e-05	0.000262	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—F2—systemic lupus erythematosus	1.59e-05	0.000256	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD80—systemic lupus erythematosus	1.53e-05	0.000246	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.42e-05	0.000228	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.42e-05	0.000228	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—systemic lupus erythematosus	1.41e-05	0.000226	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—systemic lupus erythematosus	1.39e-05	0.000223	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.38e-05	0.000222	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.32e-05	0.000211	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.31e-05	0.000211	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—systemic lupus erythematosus	1.29e-05	0.000208	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.29e-05	0.000207	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.27e-05	0.000203	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—systemic lupus erythematosus	1.26e-05	0.000203	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—systemic lupus erythematosus	1.25e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EP300—systemic lupus erythematosus	1.25e-05	0.0002	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—systemic lupus erythematosus	1.21e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.18e-05	0.00019	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.18e-05	0.000189	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—systemic lupus erythematosus	1.16e-05	0.000187	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—systemic lupus erythematosus	1.13e-05	0.000181	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—systemic lupus erythematosus	1.11e-05	0.000179	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—systemic lupus erythematosus	1.11e-05	0.000178	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.1e-05	0.000176	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.08e-05	0.000174	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—systemic lupus erythematosus	1.08e-05	0.000173	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.07e-05	0.000172	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.07e-05	0.000172	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.07e-05	0.000171	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—systemic lupus erythematosus	1.02e-05	0.000163	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.02e-05	0.000163	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.01e-05	0.000163	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—systemic lupus erythematosus	9.87e-06	0.000159	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	9.7e-06	0.000156	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EP300—systemic lupus erythematosus	9.63e-06	0.000155	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—EP300—systemic lupus erythematosus	9.2e-06	0.000148	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	9.14e-06	0.000147	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.12e-06	0.000147	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—EP300—systemic lupus erythematosus	8.46e-06	0.000136	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.37e-06	0.000135	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—EP300—systemic lupus erythematosus	8.21e-06	0.000132	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—systemic lupus erythematosus	8.17e-06	0.000131	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—systemic lupus erythematosus	6.31e-06	0.000101	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	6.12e-06	9.83e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.97e-06	9.6e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	5.77e-06	9.27e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.5e-06	8.84e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	5.27e-06	8.46e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	5.19e-06	8.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	4.96e-06	7.97e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.82e-06	7.74e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	4.54e-06	7.29e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	4.01e-06	6.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	3.77e-06	6.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.77e-06	6.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.39e-06	5.45e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.24e-06	5.21e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.97e-06	4.77e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.47e-06	3.96e-05	CbGpPWpGaD
